🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,156
Companies
1,062
Drugs tracked
3,385

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

1,254 results for “First” Clear

  1. CM313 (SC)

    First Tracks Biotherapeutics

    Pemphigus Disease

    phase 2 small molecule active

    1 trial

  2. CM336 Injection

    First Tracks Biotherapeutics

    Autoimmune Bullous Disease

    phase 2 mab active

    1 trial

  3. CMOP±R

    First Tracks Biotherapeutics

    NHL

    phase 2 small molecule active

    1 trial

  4. Cadonilimab

    First Tracks Biotherapeutics

    Lung Cancer

    phase 2 small molecule active

    1 trial

  5. Cadonilimab

    First Tracks Biotherapeutics

    Immunotherapy

    phase 2 small molecule active

    1 trial

  6. Cadonilimab

    First Tracks Biotherapeutics

    Recurrent or Metastatic Esophageal Squamous Cell Carcinoma

    phase 2 small molecule active

    1 trial

  7. Camrelizumab

    First Tracks Biotherapeutics

    Locally Advanced or Metastatic Gastric Adenocarcinoma

    phase 2 small molecule active

    1 trial

  8. Camrelizumab

    First Tracks Biotherapeutics

    Lung Cancer, Nonsmall Cell

    phase 2 small molecule active

    1 trial

  9. Camrelizumab

    First Tracks Biotherapeutics

    Nasopharyngeal Carcinoma

    phase 2 small molecule active

    1 trial

  10. Camrelizumab

    First Tracks Biotherapeutics

    Melanoma

    phase 2 small molecule active

    1 trial

  11. Camrelizumab

    First Tracks Biotherapeutics

    Breast Cancer

    phase 2 small molecule completed

    1 trial

  12. Camrelizumab

    First Tracks Biotherapeutics

    Gastric Cancer Stage III

    phase 2 small molecule active

    1 trial

  13. Camrelizumab

    First Tracks Biotherapeutics

    Lung Neoplasms

    phase 2 small molecule active

    1 trial

  14. Camrelizumab with vinorelbine and cisplatin

    First Tracks Biotherapeutics

    HER2-negative Breast Cancer

    phase 2 small molecule active

    1 trial

  15. Cangpo Liujun Prescription

    First Tracks Biotherapeutics

    Cancer-Related Fatigue

    phase 2 small molecule active

    1 trial

  16. Capecitabine

    First Tracks Biotherapeutics

    Biliary Carcinoma

    phase 2 small molecule active

    1 trial

  17. Capecitabine-Oxaliplatin-Irinotecan Combination

    First Tracks Biotherapeutics

    Unresectable Metastatic Colorectal Cancer

    phase 2 small molecule active

    1 trial

  18. Chidamide

    First Tracks Biotherapeutics

    Neuroendocrine Tumors

    phase 2 small molecule active

    2 trials

  19. Chidamide Combined with NKG2D CAR-NK Cell Therapy

    First Tracks Biotherapeutics

    HIV (Human Immunodeficiency Virus)

    phase 2 small molecule active

    1 trial

  20. Chidamide combined with Duvillisib

    First Tracks Biotherapeutics

    Peripheral T Cell Lymphoma

    phase 2 small molecule active

    1 trial

  21. Cisplatin+Capecitabine+Sintilimab

    First Tracks Biotherapeutics

    Esophageal Squamous Cell Carcinoma

    phase 2 small molecule active

    1 trial

  22. Clostridium Butyricum Tablets

    First Tracks Biotherapeutics

    Bladder (Urothelial, Transitional Cell) Cancer

    phase 2 small molecule active

    1 trial

  23. Combination therapy (COMB)

    First Tracks Biotherapeutics

    Esophageal Squamous Cell Carcinoma (ESCC)

    phase 2 small molecule active

    1 trial

  24. Combinations

    First Tracks Biotherapeutics

    Colorectal Cancer

    phase 2 small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources